FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2585830102> ?p ?o ?g. }

• W2585830102 endingPage "015021" @default.
• W2585830102 startingPage "015021" @default.
• W2585830102 abstract "Notwithstanding their wide exploitation, biological prosthetic heart valves are characterized by limited durability (10-15 years). The treatment of biological tissues with chemical crosslinking agents such as glutaraldehyde accounts for the enhanced risk of structural deterioration associated with the early failure of bioprosthetic valves. To overcome the shortcomings of the currently available solutions, adoption of decellularized biological tissues of animal origin has emerged as a promising approach. The present study aims to assess in vitro cardiovascular scaffolds composed of bovine pericardium decellularized with the novel TRITDOC (TRIton-X100 and TauroDeOxyCholic acid) procedure. The effects of the treatment have been assessed by means of histological, biomolecular, cellular, biochemical and biomechanical analyses. The TRITDOC procedure grants the complete decellularization of bovine pericardial scaffolds while preserving the extracellular matrix architecture and the biomechanical properties. With a dedicated ELISA test, the TRITDOC procedure has been proven to ensure the complete removal of the alphaGal antigen, responsible for hyperacute rejection and for long-term deterioration of xenogenic biomaterials. Static seeding of the acellular pericardial patches with human adipose-derived stem cells resulted in an evenly repopulated scaffold without signs of calcification. The in vitro cyto-/immuno-compatibility response of the TRITDOC-bovine pericardium was compared with glutaraldehyde-treated xenogenic pericardium collected from two bioprosthetic devices currently used in clinical practice: PERIMOUNT MAGNA and TRIFECTATM. TRITDOC-bovine pericardium exhibited lower complement activation, lower cytotoxicity and a lower tendency to secrete pro-inflammatory cytokines compared to the tested commercial bioprostheses. Therefore, TRITDOC-decellularized pericardium could be considered as possible candidate material for the production of prosthetic heart valves." @default.
• W2585830102 created "2017-02-10" @default.
• W2585830102 creator A5005835919 @default.
• W2585830102 creator A5007290176 @default.
• W2585830102 creator A5007981453 @default.
• W2585830102 creator A5011246055 @default.
• W2585830102 creator A5025875546 @default.
• W2585830102 creator A5028666036 @default.
• W2585830102 creator A5054097399 @default.
• W2585830102 creator A5062435112 @default.
• W2585830102 creator A5063055898 @default.
• W2585830102 creator A5072593015 @default.
• W2585830102 creator A5077743530 @default.
• W2585830102 creator A5086012653 @default.
• W2585830102 date "2017-02-03" @default.
• W2585830102 modified "2023-09-26" @default.
• W2585830102 title "<i>In vitro</i> comparative assessment of decellularized bovine pericardial patches and commercial bioprosthetic heart valves" @default.
• W2585830102 cites W1504272933 @default.
• W2585830102 cites W1970066841 @default.
• W2585830102 cites W1974921987 @default.
• W2585830102 cites W1976472429 @default.
• W2585830102 cites W1980288137 @default.
• W2585830102 cites W1980834102 @default.
• W2585830102 cites W1985398384 @default.
• W2585830102 cites W1996031005 @default.
• W2585830102 cites W1998381517 @default.
• W2585830102 cites W2020024039 @default.
• W2585830102 cites W2021548082 @default.
• W2585830102 cites W2025082573 @default.
• W2585830102 cites W2032255522 @default.
• W2585830102 cites W2034462747 @default.
• W2585830102 cites W2036918577 @default.
• W2585830102 cites W2048769067 @default.
• W2585830102 cites W2053831626 @default.
• W2585830102 cites W2057858257 @default.
• W2585830102 cites W2059192898 @default.
• W2585830102 cites W2074749249 @default.
• W2585830102 cites W2074814160 @default.
• W2585830102 cites W2075608853 @default.
• W2585830102 cites W2090303367 @default.
• W2585830102 cites W2098252984 @default.
• W2585830102 cites W2112352595 @default.
• W2585830102 cites W2121996637 @default.
• W2585830102 cites W2124826570 @default.
• W2585830102 cites W2132795383 @default.
• W2585830102 cites W2143098882 @default.
• W2585830102 cites W2153161858 @default.
• W2585830102 cites W2156922522 @default.
• W2585830102 cites W2166746075 @default.
• W2585830102 cites W2196906371 @default.
• W2585830102 cites W2346143780 @default.
• W2585830102 cites W2582364262 @default.
• W2585830102 doi "https://doi.org/10.1088/1748-605x/aa5644" @default.
• W2585830102 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28157718" @default.
• W2585830102 hasPublicationYear "2017" @default.
• W2585830102 type Work @default.
• W2585830102 sameAs 2585830102 @default.
• W2585830102 citedByCount "36" @default.
• W2585830102 countsByYear W25858301022017 @default.
• W2585830102 countsByYear W25858301022018 @default.
• W2585830102 countsByYear W25858301022019 @default.
• W2585830102 countsByYear W25858301022020 @default.
• W2585830102 countsByYear W25858301022021 @default.
• W2585830102 countsByYear W25858301022022 @default.
• W2585830102 countsByYear W25858301022023 @default.
• W2585830102 crossrefType "journal-article" @default.
• W2585830102 hasAuthorship W2585830102A5005835919 @default.
• W2585830102 hasAuthorship W2585830102A5007290176 @default.
• W2585830102 hasAuthorship W2585830102A5007981453 @default.
• W2585830102 hasAuthorship W2585830102A5011246055 @default.
• W2585830102 hasAuthorship W2585830102A5025875546 @default.
• W2585830102 hasAuthorship W2585830102A5028666036 @default.
• W2585830102 hasAuthorship W2585830102A5054097399 @default.
• W2585830102 hasAuthorship W2585830102A5062435112 @default.
• W2585830102 hasAuthorship W2585830102A5063055898 @default.
• W2585830102 hasAuthorship W2585830102A5072593015 @default.
• W2585830102 hasAuthorship W2585830102A5077743530 @default.
• W2585830102 hasAuthorship W2585830102A5086012653 @default.
• W2585830102 hasConcept C136229726 @default.
• W2585830102 hasConcept C141071460 @default.
• W2585830102 hasConcept C142724271 @default.
• W2585830102 hasConcept C185592680 @default.
• W2585830102 hasConcept C189165786 @default.
• W2585830102 hasConcept C190672674 @default.
• W2585830102 hasConcept C192562407 @default.
• W2585830102 hasConcept C202751555 @default.
• W2585830102 hasConcept C2777529624 @default.
• W2585830102 hasConcept C2778875491 @default.
• W2585830102 hasConcept C49892992 @default.
• W2585830102 hasConcept C55493867 @default.
• W2585830102 hasConcept C71924100 @default.
• W2585830102 hasConcept C86803240 @default.
• W2585830102 hasConcept C95444343 @default.
• W2585830102 hasConceptScore W2585830102C136229726 @default.
• W2585830102 hasConceptScore W2585830102C141071460 @default.
• W2585830102 hasConceptScore W2585830102C142724271 @default.
• W2585830102 hasConceptScore W2585830102C185592680 @default.
• W2585830102 hasConceptScore W2585830102C189165786 @default.

• next